BUSINESS
Short Call | Fed pauses rate cuts but what it means for RBI; JSW Infra, Bajaj Auto in focus
At all times, in all markets, in all parts of the world, the tiniest change in rates changes the value of every financial asset. - Warren Buffett
BUSINESS
Maruti Suzuki's steady Q3 sparks positivity among brokerages on future prospects
Maruti Suzuki's steady margins in Q3 in the face of muted demand growth impressed the Street. Brokerages have assigned price targets of up to Rs 14,942 for Maruti Suzuki shares.
BUSINESS
Tata Motors shares skid 9% as weak Q3, JLR slowdown sparks concerns
Tata Motors' Q3 performance struggled under margin pressure and weak earnings, impacted by a demand slowdown, especially in China, prompting brokerages to trim price targets to as low as Rs 660.
BUSINESS
Sun Pharma Q3 Preview: Double-digit India, US sales to power mid-teen profit growth
Sun Pharma's Q3 earnings may see a slight setback in margins, pressured by increased R&D expenses and a lower contribution from cancer drug Revlimid.
BUSINESS
'DeepSeek's emergence an opportunity, not threat,' clarifiy Netweb, Anant Raj; shares surge up to 10%
Netweb Tech and Anant Raj shares recovered some lost ground after the stocks were hammered in the previous session amid a global AI stock rout triggered by China's AI-startup DeepSeek.
BUSINESS
Cipla set to launch key drugs Abraxane and Advair in FY26
Cipla's oncology drug Abraxane will be launched from its Goa facility while respiratory drug Advair will be rolled out from the New Jersey plant.
BUSINESS
Hong Kong shares rise after China's DeepSeek triggers rout in global AI stocks
DeepSeek Impact: Japan’s chipmaker stocks plunged into losses, while artificial intelligence and related stocks on Wall Street were hammered overnight amid concerns over the waning dominance of US tech giants in the AI space.
BUSINESS
ICICI Bank's solid Q3 earnings impresses brokerages, ushers bullishness over asset quality, superior growth
Brokerages were especially impressed by ICICI Bank's strong CASA growth in Q3 that bucked the industry trend of a decline. In addition, stable asset quality, superior execution and steady growth kept brokerages bullish over the lender's growth prospects.
BUSINESS
Cipla Q3 Preview: Weak US sales to cap revenue growth, steady India biz to offer support
Cipla's US sales are expected to be adversely impacted by price erosion and supply disruptions for tumor drug Lanreotide, capping revenue growth.
BUSINESS
Dr Reddy's stock plunges 6% as Revlimid revenue concerns loom large despite positive Q3 earnings
Revlimid, which has arguably been the single biggest growth driver for Dr Reddy's in recent years, is set to go off patent in January 2026, sparking concerns of a huge revenue void for the drugmaker.
BUSINESS
MC Market Poll: Experts hope government won't hike capital gains tax again in Budget 2025
Moneycontrol's latest Market Poll reveals a 91 percent respondents do not expect a capital gains tax hike in the upcoming Budget. The poll included nearly four dozen participants from broking firms, mutual funds, AIFs, PMS, and independent experts.
BUSINESS
Dr Reddy's Labs Q3 Preview: Lower Revlimid contribution, subdued US sales to dent earnings growth
Analysts anticipate lower sales of blockbuster cancer drug Revlimid to squeeze Dr Reddy's margins for Q3, thereby dragging earnings growth.
BUSINESS
Zomato tanks 9% after Blinkit's aggressive expansion hits Q3 earnings, but brokerages still optimistic
Zomato's aggressive store expansion for its quick commerce business, Blinkit, has inflated losses and dragged its Q3 net profit. While the Street beat Zomato's shares down after Q3 numbers, brokerages continue to show confidence in the company's strong execution record to deliver long-term growth.
BUSINESS
Short Call | Are investors turning too picky for Q3 earnings season? Wipro, Bharat Dynamics in focus
"We believe that if a market is so overvalued that you can only find a few stocks to buy, you are probably better off not buying anything." - Arnold Van Den Berg
BUSINESS
Brokerages cautious over Tech Mahindra, see tougher road to recovery ahead
Tech Mahindra is slowing moving ahead in its three-year turnaround plan, aiming to tackle the company's slowing growth. With consistent improvement in the first three quarters of FY25, brokerages believe the path to recovery ahead with get much tougher.
BUSINESS
Wipro shares zoom 8% after better-than-expected Q3, upbeat brokerage views
Wipro delivered better-than-expected Q3 earnings, marked by a fourth straight quarter of margin expansion, which pushed its EBIT margin to a three-year high. In response to the strong margin performance, several brokerages have revised their estimates for the company upward.
BUSINESS
Wipro ADRs surge 4% after Q3 earnings beat, multi-year high margins
Wipro's Q3 net profit and revenue came well above the Street's estimates while operational efficiencies and cost optimisation helped the IT major improve its EBIT margin to 17.5 percent, the highest in three years.
BUSINESS
Tech Mahindra to deliver wage hikes in Q4, adverse margin impact likely
Ahead of Tech Mahindra's Q3 results, the market was eagerly anticipating updates on the company's wage hike timeline. The wage hike is expected to adversely impact Q4 margins, with an estimated impact of 1-1.15 percent.
BUSINESS
Union Budget 2025: Should investors be worried about a possible hike in capital gains tax?
Budget 2025: The capital gains tax hike in the last budget raised concerns among investors about the potential for future increases. While the likelihood of another hike in quick succession seems low, it cannot be entirely dismissed. Any unexpected move on capital gains tax could lead to a sharper market downturn, amplifying existing anxieties.
BUSINESS
Sensex, Nifty slip into red amid weak global cues; banks, IT puts pressure, RIL arrests fall
A selloff in major IT and banking stocks, coupled with weak global cues and profit-booking, ended the three-day winning streak for Nifty and Sensex, pushing them into the red.
BUSINESS
Infosys shares tank 6% amid likely weak Q4, uncertainty over wage hike impact
Infosys share price slumped after analysts flagged that while FY25 revenue guidance was raised to reflect the Q3 beat, the unchanged ask rate for Q4 signals potential seasonal weakness.
BUSINESS
Infosys' better-than-expected Q3 earnings ushers optimism among brokerages
Brokerages are bullish over Infosys' upbeat management commentary, hinting a recovery in demand--primarily across European financial services and US retail segments.
BUSINESS
Infosys shares may open lower after ADRs plunge 6% on likely weakness in Q4
Infosys' revised revenue growth guidance indicates a weaker Q4, likely contributing to the decline in its ADRs. This drop suggests a potential weakness in the company's domestic shares when trading resumes in the Indian stock market on January 17.
BUSINESS
Large deals pipeline strong; underlying sentiment positive, says Infosys
Infosys reported a $2.5 billion large deal TCV in Q3, raised FY25 revenue growth guidance to 4.5-5 percent, and highlighted improved client sentiment amid growing focus on AI and cost optimisation.
